Yonhap Infomax NewsMay 25, 2025
Samsung Biologics Co. has secured 440.5 billion won ($322 million) in new CDMO contracts, pushing its 2025 order intake past 3 trillion won and accelerating global expansion.
#YonhapInfomax #SamsungBiologics #CDMOContracts #OrderIntake #Biopharmaceuticals #CapacityExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64561
Samsung Biologics Secures 440.5 Billion Won CDMO Contracts—Annual Orders Surpass 3 Trillion Won (Comprehensive)

Samsung Biologics Co. has secured 440.5 billion won ($322 million) in new CDMO contracts, pushing its 2025 order intake past 3 trillion won and accelerating global expansion.

Yonhap Infomax